NSE ScannerFMCG & Food · Food: Major Diversified · NSE: ZYDUSWELL · data 2026-10-30
Zydus Wellness Limited
In plain words
Price: 24.4% below its 52-week high of ₹611.85.
Delivery: 44.4% of traded shares were kept for delivery over the last 10 sessions, against 43.7% over the last 60.
Latest results: a net loss of ₹40 cr for the quarter ended Dec 2025 (-723.4% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹4,537 cr |
| Net profit (last 12 months) | ₹188 cr |
| Sales growth, 3 years (yearly) | 20.6% |
| Profit growth, 3 years (yearly) | -14.0% |
Latest results in brief (Q3 FY25)
ZYDUSWELL Q3 FY25 results (consolidated figures, as filed on NSE).
Revenue was ₹461.9 crore, down 6.3% QoQ.
Net profit was ₹6.4 crore, down 69.4% QoQ.
Operating margin was 3.2%.
EPS was ₹1.01, down 69.2% QoQ.
ZYDUSWELL के Q3 FY25 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹461.9 करोड़; पिछली तिमाही की तुलना में 6.3% की गिरावट।
शुद्ध मुनाफ़ा: ₹6.4 करोड़; पिछली तिमाही की तुलना में 69.4% की गिरावट।
ऑपरेटिंग मार्जिन: 3.2%।
EPS: ₹1.01; पिछली तिमाही की तुलना में 69.2% की गिरावट।
ZYDUSWELLના Q3 FY25 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹461.9 કરોડ; ગયા ક્વાર્ટરની સરખામણીએ 6.3% ઘટાડો.
ચોખ્ખો નફો: ₹6.4 કરોડ; ગયા ક્વાર્ટરની સરખામણીએ 69.4% ઘટાડો.
ઓપરેટિંગ માર્જિન: 3.2%.
EPS: ₹1.01; ગયા ક્વાર્ટરની સરખામણીએ 69.2% ઘટાડો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
24/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 10/30: Delivery 44.7% over the last 20 sessions vs 26.4% in the 40 before (1.69x); shares delivered per day 0.4x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 9/15: 4 schemes hold it, about ₹2,129 cr in all (as of 2026-09-30). Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Dividend ● Split ● Results
- 17 Jul 26Dividend Dividend ₹1.2 (ex-date) +0.1% next session
- 18 Sept 25Split Split: face value ₹10 → ₹2 (ex-date)
- 11 Jul 25Dividend Dividend ₹6 (ex-date) -0.1% next session
- 4 Feb 25Results Q3 FY25 results: net profit ₹6.4 cr -3.2% next session
- 11 Nov 24Results Q2 FY25 results: net profit ₹20.9 cr -3.0% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Dec 2025 | ₹965 cr | ₹-40 cr | -723.4% | 6.3% | -1.25 |
| Jun 2025 | ₹861 cr | ₹128 cr | — | 18.1% | 20.1 |
| Dec 2024 | ₹462 cr | ₹6 cr | — | 3.2% | 1.01 |
| Mar 2024 | ₹783 cr | ₹150 cr | +3.2% | 20.7% | 23.62 |
Shareholding trend
| Holder | Jun 2026 |
|---|---|
| Promoters | 69.64% |
| Foreign institutions (FII) | 3.32% |
| Domestic institutions (DII) | 19.14% |
| Mutual funds | 18.73% |
| Retail investors | 5.45% |
| Number of shareholders | 86,866 |
Common questions
What was Zydus Wellness Limited's latest quarterly profit?
Zydus Wellness Limited reported a net loss of ₹40 cr for the quarter ended Dec 2025 (-723.4% on the same quarter a year earlier), on revenue of ₹965 cr.
How much do promoters hold in Zydus Wellness Limited?
Promoters held 69.64% of Zydus Wellness Limited at the end of Jun 2026, with 0.00% of promoter shares pledged.
Is Zydus Wellness Limited debt-free?
Its latest reported debt-to-equity ratio is 0.55.
What is Zydus Wellness Limited's P/E ratio?
About 78.2, based on the last 12 months' earnings and a price of ₹462.75 (data 2026-10-30).
What is the 52-week high and low of Zydus Wellness Limited?
The 52-week high is ₹611.85 and the 52-week low is ₹367.55.
Mutual funds holding Zydus Wellness Limited
From the monthly portfolios of the fund houses the site reads, as of 2026-09-30. 4 schemes holding about ₹2,129 cr; funds that hold it outside their top holdings may not be listed.
| Scheme | Fund house | % of fund | Value |
|---|---|---|---|
| Parag Parikh Flexi Cap Fund | PPFAS Mutual Fund | 0.78% | ₹1,132 cr |
| NIPPON INDIA SMALL CAP FUND | Nippon India Mutual Fund | 1.09% | ₹882 cr |
| Parag Parikh ELSS Tax Saver Fund | PPFAS Mutual Fund | 1.10% | ₹59 cr |
| Nippon India Consumption Fund | Nippon India Mutual Fund | 2.48% | ₹56 cr |
Similar companies
Nestle India Ltd. (NESTLEIND) · Bombay Burmah Trading Corp. Ltd. (BBTC) · Sanstar Limited (SANSTAR) · Dhunseri Ventures Limited (DVL) · BCL Industries Ltd (BCLIND)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open ZYDUSWELL in NSE Scanner →